TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 150 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,421,085 | +133.7% | 1,263,721 | +118.5% | 1.82% | +151.8% |
| Q4 2022 | $12,160,976 | +25.0% | 578,268 | +46.5% | 0.72% | +27.6% |
| Q3 2022 | $9,725,000 | +88.8% | 394,678 | +85.6% | 0.57% | +31.9% |
| Q2 2022 | $5,151,000 | -69.6% | 212,593 | -67.7% | 0.43% | -66.7% |
| Q1 2022 | $16,963,000 | -47.5% | 658,249 | -36.8% | 1.29% | -31.8% |
| Q4 2021 | $32,308,000 | +204.7% | 1,040,858 | +138.0% | 1.89% | +200.5% |
| Q3 2021 | $10,604,000 | – | 437,280 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |